鲁索替尼 | 鲁索利替尼 | 芦可替尼
Ruxolitinib | INCB018424 | Ruxolitinib Free base | (R)-Ruxolitinib
ChemLeader
Catalog No:
CAS No.:
MDLNo:
Formula:
MW:
Size
Quantity
- +
Product Overview
Product Name Ruxolitinib | INCB018424 | Ruxolitinib Free base | (R)-Ruxolitinib
CAS941678-49-5
FormulaC17H18N6
MW306.37
AppearanceWhite to light yellow powder
Storage conditionStore in a dry and dark sealed container, short-term (weeks to months) storage at 0-4 ℃, long-term (months to years) storage at -20 ℃.
Security information
Product details

Ruxolitinib is the first potent, selective, JAK1/2 inhibitor to enter the clinic with IC50 of 3.3 nM/2.8 nM in cell-free assays, >130-fold selectivity for JAK1/2 versus JAK3. Ruxolitinib kills tumor cells through toxic mitophagy. Ruxolitinib induces autophagy and enhances apoptosis.

Related
Sorry, no related items
History
Orforglipron | LY3502970 | GLP-1 receptor agonist 1
Ruxolitinib | INCB018424 | Ruxolitinib Free base | (R)-Ruxolitinib
Shanzhiside
Calcitonin Acetate(Salmon); Salcitonin Acetate
Etoposide phosphate
Capsiate
Vinpocetine
Tris |Tromethamine |THAM
Abrocitinib (Synonyms: PF-04965842; N-[cis-3-(Methyl-7H-pyrrolo[2,3-d]pyrimidin-4-ylamino)cyclobutyl]-1-propanesulfonamide | N-{cis-3-[Methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino]cyclobutyl}-propane-1-sulfonamide)
(S)-2-(tert-butyl)piperazine